Your browser doesn't support javascript.
loading
Deficiency in Galectin-3, -8, and -9 impairs immunity to chronic Mycobacterium tuberculosis infection but not acute infection with multiple intracellular pathogens.
Morrison, Huntly M; Craft, Julia; Rivera-Lugo, Rafael; Johnson, Jeffery R; Golovkine, Guillaume R; Bell, Samantha L; Dodd, Claire E; Van Dis, Erik; Beatty, Wandy L; Margolis, Shally R; Repasy, Teresa; Shaker, Isaac; Lee, Angus Y; Vance, Russell E; Stanley, Sarah A; Watson, Robert O; Krogan, Nevan J; Portnoy, Daniel A; Penn, Bennett H; Cox, Jeffery S.
Affiliation
  • Morrison HM; Department of Molecular and Cell Biology, Division of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, California, United States of America.
  • Craft J; Department of Internal Medicine, Division of Infectious Diseases, University of California, Davis, Davis, California, United States of America.
  • Rivera-Lugo R; Department of Molecular and Cell Biology, Division of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, California, United States of America.
  • Johnson JR; Department of Cellular and Molecular Pharmacology, University of California, San Francisco; Quantitative Biosciences Institute (QBI), University of California, San Francisco; Gladstone Institutes, San Francisco, California, United States of America.
  • Golovkine GR; Department of Molecular and Cell Biology, Division of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, California, United States of America.
  • Bell SL; Department of Microbial Pathogenesis and Immunology, Texas A&M Health, School of Medicine, Bryan, Texas, United States of America.
  • Dodd CE; Department of Molecular and Cell Biology, Division of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, California, United States of America.
  • Van Dis E; Department of Molecular and Cell Biology, Division of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, California, United States of America.
  • Beatty WL; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, United States of America.
  • Margolis SR; Department of Molecular and Cell Biology, Division of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, California, United States of America.
  • Repasy T; Department of Molecular and Cell Biology, Division of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, California, United States of America.
  • Shaker I; Department of Internal Medicine, Division of Infectious Diseases, University of California, Davis, Davis, California, United States of America.
  • Lee AY; Cancer Research Laboratory, University of California, Berkeley, Berkeley, California, United States of America.
  • Vance RE; Department of Molecular and Cell Biology, Division of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, California, United States of America.
  • Stanley SA; Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, California, United States of America.
  • Watson RO; Department of Molecular and Cell Biology, Division of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, California, United States of America.
  • Krogan NJ; School of Public Health, Division of Infectious Diseases and Vaccinology, University of California, Berkeley, Berkeley, California, United States of America.
  • Portnoy DA; Department of Microbial Pathogenesis and Immunology, Texas A&M Health, School of Medicine, Bryan, Texas, United States of America.
  • Penn BH; Department of Cellular and Molecular Pharmacology, University of California, San Francisco; Quantitative Biosciences Institute (QBI), University of California, San Francisco; Gladstone Institutes, San Francisco, California, United States of America.
  • Cox JS; Department of Molecular and Cell Biology, Division of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, California, United States of America.
PLoS Pathog ; 19(6): e1011088, 2023 06.
Article in En | MEDLINE | ID: mdl-37352334
ABSTRACT
Macrophages employ an array of pattern recognition receptors to detect and eliminate intracellular pathogens that access the cytosol. The cytosolic carbohydrate sensors Galectin-3, -8, and -9 (Gal-3, Gal-8, and Gal-9) recognize damaged pathogen-containing phagosomes, and Gal-3 and Gal-8 are reported to restrict bacterial growth via autophagy in cultured cells. However, the contribution of these galectins to host resistance during bacterial infection in vivo remains unclear. We found that Gal-9 binds directly to Mycobacterium tuberculosis (Mtb) and Salmonella enterica serovar Typhimurium (Stm) and localizes to Mtb in macrophages. To determine the combined contribution of membrane damage-sensing galectins to immunity, we generated Gal-3, -8, and -9 triple knockout (TKO) mice. Mtb infection of primary macrophages from TKO mice resulted in defective autophagic flux but normal bacterial replication. Surprisingly, these mice had no discernable defect in resistance to acute infection with Mtb, Stm or Listeria monocytogenes, and had only modest impairments in bacterial growth restriction and CD4 T cell activation during chronic Mtb infection. Collectively, these findings indicate that while Gal-3, -8, and -9 respond to an array of intracellular pathogens, together these membrane damage-sensing galectins play a limited role in host resistance to bacterial infection.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Mycobacterium tuberculosis Limits: Animals Language: En Journal: PLoS Pathog Year: 2023 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Mycobacterium tuberculosis Limits: Animals Language: En Journal: PLoS Pathog Year: 2023 Document type: Article Affiliation country: Estados Unidos
...